Search Results

Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-activated Technology in Hospital Settings

Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference.

Baxter to Present at Barclays 27th Annual Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.      The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 8, 2025. 

Baxter Reports Fourth-Quarter and Full-Year 2024 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025. 

Baxter to Present at TD Cowen 45th Annual Health Care Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time.      The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 1, 2025. 

Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time.     

Baxter to Present at Citi – 2025 Medtech & Life Sciences Access Day

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.    The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Tuesday, August 26, 2025. 

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter

Baxter Announces CEO Retirement and Appointment of COO

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025.

A Conversation About Baxter’s Role in Healthcare Connectivity

In healthcare, connectivity refers to the sharing and integration of data across devices, systems and healthcare institutions. 

Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 20, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I2823858 to pre-register for the call and receive the call information.